Detalles de la búsqueda
1.
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
Ann Rheum Dis
; 78(2): 192-200, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30396903
2.
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
Ann Rheum Dis
; 76(8): 1426-1431, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28473425
3.
Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry.
Rheumatology (Oxford)
; 55(4): 659-68, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26628579
4.
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci.
Ann Rheum Dis
; 79(2): e14, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30573653
5.
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al.
Ann Rheum Dis
; 79(4): e37, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30674476
6.
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.
Rheumatology (Oxford)
; 53(11): 2100-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24939677
7.
Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry.
Arthritis Rheum
; 65(5): 1213-23, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23460467
8.
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry.
Ann Rheum Dis
; 72(7): 1149-55, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22941767
9.
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry.
Ann Rheum Dis
; 72(1): 79-82, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22945500
10.
Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry.
Clin Epidemiol
; 9: 627-632, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29238225
11.
Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
J Rheumatol
; 44(1): 59-69, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27909080
12.
[Schnitzler syndrome is a diagnostic challenge]. / Schnitzlers syndrom er en diagnostisk udfordring.
Ugeskr Laeger
; 177(30)2015 Jul 20.
Artículo
en Danés
| MEDLINE | ID: mdl-26240044
13.
Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician's Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry.
J Rheumatol
; 42(10): 1781-5, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26233511
Resultados
1 -
13
de 13
1
Próxima >
>>